BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18051322)

  • 1. Assessment of lipopolysaccharide-binding activity of Bifidobacterium and its relationship with cell surface hydrophobicity, autoaggregation, and inhibition of interleukin-8 production.
    Park MS; Kim MJ; Ji GE
    J Microbiol Biotechnol; 2007 Jul; 17(7):1120-6. PubMed ID: 18051322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditions affecting cell surface properties of human intestinal bifidobacteria.
    Canzi E; Guglielmetti S; Mora D; Tamagnini I; Parini C
    Antonie Van Leeuwenhoek; 2005; 88(3-4):207-19. PubMed ID: 16284927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of probiotic strains on interleukin 8 production by HT29/19A cells.
    Lammers KM; Helwig U; Swennen E; Rizzello F; Venturi A; Caramelli E; Kamm MA; Brigidi P; Gionchetti P; Campieri M
    Am J Gastroenterol; 2002 May; 97(5):1182-6. PubMed ID: 12014725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between surface hydrophobicity and adherence of Bifidobacterium strains from centenarians' faeces.
    Pan WH; Li PL; Liu Z
    Anaerobe; 2006 Jun; 12(3):148-52. PubMed ID: 16765861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.
    Candela M; Perna F; Carnevali P; Vitali B; Ciati R; Gionchetti P; Rizzello F; Campieri M; Brigidi P
    Int J Food Microbiol; 2008 Jul; 125(3):286-92. PubMed ID: 18524406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Production of interleukin-11 and interleukin-6 in cultured human gingival fibroblasts with the stimulation of lipopolysaccharides].
    He L; Nagasawa T; Ishikawa I
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jan; 42(1):34-6. PubMed ID: 17331441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains.
    Strozzi GP; Mogna L
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S179-84. PubMed ID: 18685499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of bovine lactoferrin on autoaggregation ability and surface hydrophobicity of bifidobacteria.
    Rahman M; Kim WS; Kumura H; Shimazaki K
    Anaerobe; 2008 Apr; 14(2):73-7. PubMed ID: 18313948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifidobacterium longum and Bifidobacterium breve isolates from preterm and full term neonates: comparison of cell surface properties.
    Andriantsoanirina V; Teolis AC; Xin LX; Butel MJ; Aires J
    Anaerobe; 2014 Aug; 28():212-5. PubMed ID: 25026303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells.
    Imaoka A; Shima T; Kato K; Mizuno S; Uehara T; Matsumoto S; Setoyama H; Hara T; Umesaki Y
    World J Gastroenterol; 2008 Apr; 14(16):2511-6. PubMed ID: 18442197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide (LPS) labeled with Alexa 488 hydrazide as a novel probe for LPS binding studies.
    Triantafilou K; Triantafilou M; Fernandez N
    Cytometry; 2000 Dec; 41(4):316-20. PubMed ID: 11084617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide neutralization by the antibacterial peptide CM4.
    Lin QP; Zhou LF; Li NN; Chen YQ; Li BC; Cai YF; Zhang SQ
    Eur J Pharmacol; 2008 Oct; 596(1-3):160-5. PubMed ID: 18789317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portrait of a canine probiotic Bifidobacterium--from gut to gut.
    O'Mahony D; Murphy KB; MacSharry J; Boileau T; Sunvold G; Reinhart G; Kiely B; Shanahan F; O'Mahony L
    Vet Microbiol; 2009 Oct; 139(1-2):106-12. PubMed ID: 19523775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation of Lactobacilli and Bifidobacteria with Escherichia coli O157.
    Bujnáková D; Vlková E; Rada V; Kmet V
    Folia Microbiol (Praha); 2004; 49(2):143-6. PubMed ID: 15227785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPS-induced MCP-1 and IL-6 production is not reversed by oestrogen in human periodontal ligament cells.
    Jönsson D; Nebel D; Bratthall G; Nilsson BO
    Arch Oral Biol; 2008 Sep; 53(9):896-902. PubMed ID: 18554572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of composition of the core region of Escherichia coli K-12 lipopolysaccharides on the surface properties of cells].
    Zubova SV; Ivanov AIu; Prokhorenko IR
    Mikrobiologiia; 2008; 77(3):336-41. PubMed ID: 18683650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
    Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
    Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyanobacterial LPS antagonist (CyP)-a novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig.
    Thorgersen EB; Macagno A; Rossetti C; Mollnes TE
    Mol Immunol; 2008 Aug; 45(13):3553-7. PubMed ID: 18571239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut immune stimulation by non pathogenic Gram(+) and Gram(-) bacteria. Comparison with a probiotic strain.
    Dogi CA; Galdeano CM; Perdigón G
    Cytokine; 2008 Mar; 41(3):223-31. PubMed ID: 18248820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antagonistic properties of bifidobacteria isolated from different natural sources].
    Poltavs'ka OA; Kovalenko NK
    Mikrobiol Z; 2005; 67(2):70-80. PubMed ID: 16018219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.